Literature DB >> 1937385

Azathioprine hepatotoxicity after liver transplantation.

M Sterneck1, R Wiesner, N Ascher, J Roberts, L Ferrell, J Ludwig, J Lake.   

Abstract

We report the first two cases of apparent azathioprine hepatotoxicity occurring after liver transplantation. The two patients exhibited jaundice, elevated serum transaminase activities and histopathological features of sinusoidal congestion and centrilobular hepatocellular degeneration 17 and 61 days after transplantation. After withdrawal of azathioprine, liver test results improved immediately in both patients. Recurrence of liver injury after another challenge with azathioprine was seen in the first case. Previously, fatal venoocclusive disease occurring after kidney transplantation had been attributed to azathioprine. Irreversible venoocclusive disease and the reversible hepatotoxicity described in this report (i.e., sinusoidal congestion with centrizonal necrosis) most likely represent different stages of hepatic endotheliitis caused by azathioprine. Thus early diagnosis of azathioprine hepatotoxicity is of great importance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937385     DOI: 10.1002/hep.1840140511

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.

Authors:  Vishal N Patel; David C Kaelber
Journal:  J Biomed Inform       Date:  2013-10-28       Impact factor: 6.317

Review 2.  Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Authors:  Sarah Tischer; Robert J Fontana
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

3.  Venoocclusive disease of the liver following renal transplantation.

Authors:  M A Jeffries; W M McDonnell; J A Tworek; R M Merion; R H Moseley
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

4.  Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.

Authors:  Stepan Sembera; Craig Lammert; Jayant A Talwalkar; Schuyler O Sanderson; John J Poterucha; J Eileen Hay; Russell H Wiesner; Gregory J Gores; Charles B Rosen; Julie K Heimbach; Michael R Charlton
Journal:  Liver Transpl       Date:  2012-07       Impact factor: 5.799

5.  Endovascular stent placement for venous complications following pediatric liver transplantation: outcomes and indications.

Authors:  Takumi Katano; Yukihiro Sanada; Yuta Hirata; Naoya Yamada; Noriki Okada; Yasuharu Onishi; Koshi Matsumoto; Koichi Mizuta; Yasunaru Sakuma; Naohiro Sata
Journal:  Pediatr Surg Int       Date:  2019-09-18       Impact factor: 1.827

6.  Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.

Authors:  Einar S Björnsson; Jiezhun Gu; David E Kleiner; Naga Chalasani; Paul H Hayashi; Jay H Hoofnagle
Journal:  J Clin Gastroenterol       Date:  2017-01       Impact factor: 3.062

Review 7.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 8.  Types, causes, and therapies of hepatitis occurring in liver transplant recipients.

Authors:  S Fagiuoli; G Shah; H I Wright; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 9.  Hepatotoxicity Secondary to Chemotherapy.

Authors:  Alla Grigorian; Christopher B O'Brien
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

10.  Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression.

Authors:  Ta-Lun Kao; Yao-Li Chen; Yu-Ping Kuan; Wei-Chun Chang; Yu-Chen Ho; Shuyuan Yeh; Long-Bin Jeng; Wen-Lung Ma
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.